Needham analyst Mike Matson downgrades Surmodics (NASDAQ:SRDX) from Buy to Hold.
Needham Downgrades Surmodics to Hold
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.